These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34487662)

  • 41. Psoriasis Severity-A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome.
    Polic MV; Miskulin M; Smolic M; Kralik K; Miskulin I; Berkovic MC; Curcic IB
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 30011841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.
    Langan SM; Seminara NM; Shin DB; Troxel AB; Kimmel SE; Mehta NN; Margolis DJ; Gelfand JM
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):556-62. PubMed ID: 22113483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: Systematic review and meta-analysis.
    Phan K; Lee G; Fischer G
    Pediatr Dermatol; 2020 Jul; 37(4):661-669. PubMed ID: 32436322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
    Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ
    Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults.
    Can AS; Bersot TP; Gönen M; Pekcan G; Rakıcıoğlu N; Samur G; Yıldız EA
    Public Health Nutr; 2009 Apr; 12(4):538-46. PubMed ID: 18489811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psoriasis and metabolic syndrome.
    Malkic Salihbegovic E; Hadzigrahic N; Cickusic AJ
    Med Arch; 2015 Apr; 69(2):85-7. PubMed ID: 26005254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
    Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
    J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic syndrome in drug naïve schizophrenic patients.
    Anjum S; Bathla M; Panchal S; Singh GP; Singh M
    Diabetes Metab Syndr; 2018; 12(2):135-140. PubMed ID: 29191416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying adolescent metabolic syndrome using body mass index and waist circumference.
    Camhi SM; Kuo J; Young DR
    Prev Chronic Dis; 2008 Oct; 5(4):A115. PubMed ID: 18793503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study.
    Praveenkumar U; Ganguly S; Ray L; Nanda SK; Kuruvila S
    J Clin Diagn Res; 2016 Feb; 10(2):WC01-5. PubMed ID: 27042565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study.
    Tas B; Kabeloglu V
    Dermatol Pract Concept; 2021 May; 11(3):e2021049. PubMed ID: 34123557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of metabolic syndrome in Chinese psoriasis patients: A hospital-based cross-sectional study.
    Gui XY; Yu XL; Jin HZ; Zuo YG; Wu C
    J Diabetes Investig; 2018 Jan; 9(1):39-43. PubMed ID: 28371532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2).
    Menter MA; Mehta NN; Lebwohl MG; Gottlieb AB; Mendelsohn AM; Rozzo SJ; Leonardi C
    J Drugs Dermatol; 2020 Aug; 19(8):703-708. PubMed ID: 32845115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of regular walking and body mass index on metabolic syndrome among an elderly Korean population.
    Kim S; Kim DI
    Exp Gerontol; 2018 Jun; 106():178-182. PubMed ID: 29522861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.
    Delavari A; Forouzanfar MH; Alikhani S; Sharifian A; Kelishadi R
    Diabetes Care; 2009 Jun; 32(6):1092-7. PubMed ID: 19279302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of serum uric acid levels in psoriasis vulgaris.
    Yilmaz E; Tamer E; Artüz F; Külcü Çakmak S; Köktürk F
    Turk J Med Sci; 2017 Apr; 47(2):531-534. PubMed ID: 28425242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic Diseases and Associated Complications in Patients with Psoriasis.
    Bajaj S; Mandal S; Singh KG; Prajapati R
    J Assoc Physicians India; 2020 Oct; 68(10):44-46. PubMed ID: 32978925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic Syndrome and Psoriasis: A Case-Control Study in Kabul, Afghanistan.
    Aalemi AK; Bahain MB; Hamdard AG
    Diabetes Metab Syndr Obes; 2021; 14():1465-1471. PubMed ID: 33833537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The most appropriate cut-off point of anthropometric indices in predicting the incidence of metabolic syndrome and its components.
    Farhangiyan Z; Latifi SM; Rashidi H; Shahbazian H
    Diabetes Metab Syndr; 2019; 13(4):2739-2745. PubMed ID: 31405702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.